Medicine & TechnologyA new study bears importance as the work promises a cure using which patients with cancer will be saved from adverse effects caused by chemotherapy and radiation therapy.
Clair Gunn, 39, sought medical care after receiving a misdiagnosis for three years. She was initially told she had irritable bowel syndrome or IBS, but according to her most recent diagnosis, she has a terminal illness — colon cancer.
Findings of a clinical trial recently showed how a compound produced by caterpillar fungus can be a contributor to the efficacy of an anti-cancer drug.
A 53-year-old patient was the first to try the magnetic helmet developed to reduce brain tumors. The device proved effective as it indeed, shrank the tumor of this glioblastoma patient.
Researchers have recently discovered a new way of preventing further cancerous brain tumor growth. The pre-clinical research could lead to changes in how the cancer is treated.
Cancer cells have adapted hibernation, an ancient evolutionary survival mechanism, in which they transform into sluggish, slow dividing cells to evade the harsh chemotherapy.
A recent study suggests the combination of three drugs including a dehydrogenase inhibitor could overcome cancer cells that have become drug resistant.
The team discovered that inhibiting ID1 slows the progression of tumors in glioblastoma, breast adenocarcinoma, and melanoma. In human tissue, researchers found that the protein caused cells to be more resistant to chemotherapy treatment in glioblastoma